Evidence map›Paper›PMID 35286241›Full record

ArticleVirulence2022

Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients.

Asmaa M Zahran, Mona H Abdel-Rahim, Khalid A Nasif, Safinaz Hussein, Rania Hafez, Ahmad Bahieldeen Ahmad, Khaled Saad, Amira Elhoufey, Hosni A M Hussein, Ali A Thabet and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Current Advances in Follicular Regulatory T-Cell Biology.Critical reviews in immunology · 2022
    Review
  8. Review
  9. COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Asmaa M ZahranDepartment of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Mona H Abdel-RahimDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Khalid A NasifDepartment of Medical Biochemistry, Faculty of Medicine, Minia University, Minia, Egypt.
Safinaz HusseinDepartment of Internal Medicine, Clinical Hematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt.
Rania HafezDepartment of Internal Medicine, Clinical Hematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ahmad Bahieldeen AhmadDepartment of Internal Medicine, Critical Care Unit, Faculty of Medicine, Assiut University, Assiut, Egypt.
Khaled SaadDepartment of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt.
Amira ElhoufeyDepartment of Community Health Nursing, Faculty of Nursing, Assiut University, Assiut, Egypt.
Hosni A M HusseinDepartment of Microbiology, Faculty of Science, Al Azhar University, Assiut 71524, Egypt.
Ali A ThabetDepartment of Zoology, Faculty of Science, Al Azhar University, Assiut 71524, Egypt.
Omnia El-BadawyDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Assiut University · EGAl-Azhar University · EGMinia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to determine the levels of follicular helper T (Tfh) and follicular regulatory T (Tfr) cells in COVID-19 patients and determine whether their levels correlated with disease severity and presence of hyperglycemia. This study was carried out in 34 hospitalized COVID-19 patients and 20 healthy controls. Levels of total circulating Tfh, inducible T-cell costimulator (ICOS)+ activated Tfh, and Tfr cells were assessed in all participants by flow cytometry. Total CD4+CXCR5+ Tfh cells and ICOS+Foxp3-activated Tfh cells increased and ICOS+Foxp3+ Tfr cells decreased in COVID-19 patients, especially in diabetic patients and those with severe disease. Activated ICOS+ Tfh cells were directly correlated with lactate dehydrogenase, D-dimer, ferritin, and respiratory rate and inversely correlated with the partial pressure of carbon dioxide. COVID-19 is associated with marked activation of Tfh cells and a profound drop in Tfr cells, especially in severe and diabetic patients. Future studies on expanded cohorts of patients are needed to clarify the relationship between SARS-CoV-2 and acute-onset diabetes.

Indexed as

COVID-19HyperglycemiaCD4-Positive T-LymphocytesHumansSARS-CoV-2T-Lymphocytes, RegulatoryCOVID-19follicular helper Tfollicular regulatory Thyperglycemia

Identifiers

PMID35286241
PMCPMC8928811
OpenAlexW4220899315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.